Shrewsbury R P, Oliver S R, White L G
University of North Carolina, School of Pharmacy, Division of Pharmaceutics, Chapel Hill 27599-7360.
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1237-42. doi: 10.3109/10731199409138821.
Desmethylimipramine (desipramine, DMI) is predominantly 2-hydroxylated to 2-hydroxydesipramine, and the remainder is N-demethylated to didesmethylimipramine (DDMI) in both rats and man. DMI 2-hydroxylation is mediated by the same cytochrome P-450 isoenzyme (P4502D6) in rats and man. Fluosol hemodilution has previously been shown to influence the activity of P4502B1 and P4502B2, the cytochrome P-450 isoenzymes induced by phenobarbital in rats. In this study, DMI was used as a model substrate to investigate the influence of moderate Fluosol hemodilution on P4502D6 activity in rats. DMI total body clearance was not influenced by Fluosol hemodilution. This was an anticipated outcome since phenobarbital had a negligible effect on DMI metabolism, and Fluosol and phenobarbital affect the same isoenzymes. DMI Vdss was increased at 0.5 hour after hemodilution, but decreased from 24-72 hours. The decreased Vdss is most likely due to increased concentrations of alpha-1-acid-glycoprotein. Thus, Fluosol hemodilution is not expected to influence the hepatic P4502D6 activity in man. However, Fluosol may have marked influences on the apparent volumes of distribution of basic drugs that bind to alpha-1-acid-glycoprotein.
去甲丙咪嗪(地昔帕明,DMI)在大鼠和人体内主要被2-羟基化生成2-羟基地昔帕明,其余部分则发生N-去甲基化生成双去甲丙咪嗪(DDMI)。大鼠和人体内DMI的2-羟基化均由同一细胞色素P-450同工酶(P4502D6)介导。氟碳血液稀释先前已被证明会影响P4502B1和P4502B2的活性,这两种细胞色素P-450同工酶是由苯巴比妥在大鼠体内诱导产生的。在本研究中,DMI被用作模型底物,以研究适度氟碳血液稀释对大鼠P4502D6活性的影响。氟碳血液稀释并未影响DMI的全身清除率。这是一个预期的结果,因为苯巴比妥对DMI代谢的影响可忽略不计,且氟碳和苯巴比妥影响相同的同工酶。血液稀释后0.5小时DMI的稳态分布容积增加,但在24至72小时内降低。稳态分布容积降低很可能是由于α-1-酸性糖蛋白浓度增加所致。因此,预计氟碳血液稀释不会影响人体内肝脏P4502D6的活性。然而,氟碳可能会对与α-1-酸性糖蛋白结合的碱性药物的表观分布容积产生显著影响。